72 studies found for your search request: Schering-Plough/Organon studies

ALOXI (palonosetron) (MK-4291-001)
Condition: Nausea, Chemotherapy-induced
ClinicalTrials.gov Identifier: NCT00687011 (view full study on clinicaltrials.gov)
Phase: Phase IV
Company: Schering-Plough

ALOXI (palonosetron) (MK-4291-002)
Condition: Nausea, Chemotherapy-induced
ClinicalTrials.gov Identifier: NCT00684463 (view full study on clinicaltrials.gov)
Phase: Phase IV
Company: Schering-Plough

CLARINEX (desloratadine) (MK-7079-001)
Condition: Rhinitis, Seasonal Allergic
Phase: Phase II
Company: Schering-Plough

CLARINEX (desloratadine) (P02879)
Condition: Chronic Idiopathic Urticaria
Phase: Phase IV
Company: Schering-Plough

CLARINEX (desloratadine) (P02904)
Condition: Rhinitis, Seasonal Allergic
Phase: Phase III
Company: Schering-Plough

Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences Privacy Terms of Use Consumer Health Data Privacy Policy Your Privacy Choices Accessibility U.S. Corporate Site

Legacy PhRMA Studies